Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01018979 · OUTCOME

Circulating CD34+ Cell Counts in Peripheral Blood.

Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients · Source last updated 2021-05-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
cells/μL
Interval / dispersion
Standard Deviation
Time frame
Baseline, 3 hours and 6 hours after infusion

Groups in this outcome

Multiple Myeloma (MM)

7 patients with MM were enrolled.

Non-Hodgkin Lymphoma (NHL) + Hodgkin Disease (HD)

10 patients and 2 patients with NHL and HD were enrolled, respectively.

All Patients

All patents = MM + NHL + HD

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Multiple Myeloma (MM)7
Non-Hodgkin Lymphoma (NHL) + Hodgkin Disease (HD)12
All Patients19

Reported measurements

PB CD34+ count (Baseline)
Values in cells/μL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Multiple Myeloma (MM)1.00.7Not reportedNot reportedNot reported
Non-Hodgkin Lymphoma (NHL) + Hodgkin Disease (HD)0.90.5Not reportedNot reportedNot reported
All Patients1.00.6Not reportedNot reportedNot reported
PB CD34+ count (3 hours after infusion)
Values in cells/μL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Multiple Myeloma (MM)5.74.0Not reportedNot reportedNot reported
Non-Hodgkin Lymphoma (NHL) + Hodgkin Disease (HD)4.02.1Not reportedNot reportedNot reported
All Patients4.62.9Not reportedNot reportedNot reported
PB CD34+ count (6 hours after infusion)
Values in cells/μL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Multiple Myeloma (MM)6.33.9Not reportedNot reportedNot reported
Non-Hodgkin Lymphoma (NHL) + Hodgkin Disease (HD)4.32.7Not reportedNot reportedNot reported
All Patients5.13.3Not reportedNot reportedNot reported
PB CD34+ count (Maximum increase)
Values in cells/μL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Multiple Myeloma (MM)7.84.4Not reportedNot reportedNot reported
Non-Hodgkin Lymphoma (NHL) + Hodgkin Disease (HD)5.23.7Not reportedNot reportedNot reported
All Patients6.54.1Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        0.7
        value
        1.0
      2. group Id
        OG001
        spread
        0.5
        value
        0.9
      3. group Id
        OG002
        spread
        0.6
        value
        1.0
    title
    PB CD34+ count (Baseline)
  2. categories
    1. measurements
      1. group Id
        OG000
        spread
        4.0
        value
        5.7
      2. group Id
        OG001
        spread
        2.1
        value
        4.0
      3. group Id
        OG002
        spread
        2.9
        value
        4.6
    title
    PB CD34+ count (3 hours after infusion)
  3. categories
    1. measurements
      1. group Id
        OG000
        spread
        3.9
        value
        6.3
      2. group Id
        OG001
        spread
        2.7
        value
        4.3
      3. group Id
        OG002
        spread
        3.3
        value
        5.1
    title
    PB CD34+ count (6 hours after infusion)
  4. categories
    1. measurements
      1. group Id
        OG000
        spread
        4.4
        value
        7.8
      2. group Id
        OG001
        spread
        3.7
        value
        5.2
      3. group Id
        OG002
        spread
        4.1
        value
        6.5
    title
    PB CD34+ count (Maximum increase)
denoms
  1. counts
    1. group Id
      OG000
      value
      7
    2. group Id
      OG001
      value
      12
    3. group Id
      OG002
      value
      19
    units
    Participants
dispersion Type
Standard Deviation
groups
  1. description
    7 patients with MM were enrolled.
    id
    OG000
    title
    Multiple Myeloma (MM)
  2. description
    10 patients and 2 patients with NHL and HD were enrolled, respectively.
    id
    OG001
    title
    Non-Hodgkin Lymphoma (NHL) + Hodgkin Disease (HD)
  3. description
    All patents = MM + NHL + HD
    id
    OG002
    title
    All Patients
param Type
MEAN
reporting Status
POSTED
time Frame
Baseline, 3 hours and 6 hours after infusion
title
Circulating CD34+ Cell Counts in Peripheral Blood.
type
SECONDARY
unit Of Measure
cells/μL

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice